Tuberculosis a re-emerging disease

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 3, 2012, Pages 185-187

  De Lorenzo, Saverio ^a   Tiberi, Simon ^a  

^a Morelli Hospital   (Italy)

Author keywords

Foreign born; MDR; TNF inhibitors; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNICABLE DISEASE; DIRECTLY OBSERVED THERAPY; EPIDEMIC; HEALTH; HUMAN; ITALY; MIGRATION; RISK FACTOR; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASES, EMERGING; DIRECTLY OBSERVED THERAPY; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; HUMANS; ITALY; RISK FACTORS; TUBERCULOSIS; WORLD HEALTH;

EID: 84867738010     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0822-9     Document Type: Article

References (15)

1. Tuberculosis. World Health Organization Fact sheet N°104 March 2012. http://www. who. int/mediacentre/factsheets/fs104/en/. Accessed 1 Jun 2012.
2. WHO Report 2011. Global tuberculosis control. http://www. who. int/tb/data. Accessed 1 Jun 2012.
3. Rapporto Tubercolosi 2008 in Italia. Italian Ministry of Health. http://www. salute. gov. it (in Italian). Accessed 1 Jun 2012.
4. Fattorini L, Mustazzolu A, Piccaro G et al (2012) Drug-resistant tuberculosis among foreign-born persons in Italy. Eur Resp J 40: 1-4.
5. Das SK, Mukherjee RS, Ghosh IN (2007) A study of pulmonary tuberculosis in the elderly. J Indian Med Assoc 105(8): 432, 436, 438-439.
6. Gagliotti C, Resi D, Moro ML (2006) Delay in the diagnosis of pulmonary TB in a changing demographic scenario. Int J Tuberc Lung Dis 10(3): 305-309.
7. Ginsburg AS, Woolwine SC, Hooper N et al (2003) The rapid development of fluoroquinolone resistance in M. tuberculosis. N Engl J Med 349(20): 1977-1978.
8. Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE (2012) Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability. J Immunol 188(7): 3169-3178 (Epub 2012 Feb 29).
9. TB control guidelines 2010. Italian ministry of Health. http://www. salute. gov. it/imgs/C_17_pubblicazioni_1661_allegato. pdf (in Italian). Accessed 1 Jun 2012.
10. Zhao Y, Xu S, Wang L et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23): 2161-2170.
11. Sotgiu G, Centis R, D'Ambrosio L (2012) Efficacy, safety and tolerability of Linezolid containing regimens in treating MDR-TB and XDR-TB: systemic review and metanalysis. Eur Respir J [Epub ahead of print].
12. Migliori GB, Zellweger JP, Abubakar I et al (2012) European union standards for tuberculosis care. Eur Respir J 39(4): 807-819.
13. Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H et al (2012) Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 366(23): 2151-2160.
14. Diacon AH, Donald PR, Pym A et al (2012) Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother 56(6): 3271-3276 (Epub 2012 Mar 5).
15. Kempker RR, Vashakidze S, Solomonia N et al (2012) Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12(2): 157-166.